Hippocratic AI Secures $141 Million in Series B Funding, Achieving a Valuation of $1.64 Billion

Hippocratic AI has successfully completed a $141 million Series B financing round, just nine months following its Series A, bringing its valuation to $1.64 billion. Led by Kleiner Perkins, the funding will support the company’s mission to enhance healthcare delivery and patient outcomes through its innovative Polaris constellation LLM architecture, which has achieved clinical safety on par with human clinicians. In recent months, Hippocratic AI has demonstrated strong customer traction by signing contracts with 23 healthcare systems and garnering positive feedback from patients, with its GenAI agents receiving an average rating of 8.7 out of 10. The company plans to leverage its additional resources to expand into new verticals and markets, while also launching an AI Agent App Store to foster collaboration with licensed clinicians. Kleiner Perkins highlighted the significant market potential for generative AI in addressing healthcare staffing shortages, emphasizing Hippocratic AI’s leadership in this emerging category.

Hippocratic AI Secures $141 Million in Series B Funding, Achieving a Valuation of $1.64 Billion

Variety of Factors Result in Closure of Cozy Home & Lighting Storefront

Annual Impact of Dangerous Blood Clots on 22 Million: Can Light Therapy Provide a Solution?

Three Franklin Mountain Energy Sites Achieve DarkSky Certification

Survey Reveals Three-Quarter of Drivers Struggle with Dazzling Headlights